Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00069004 · ClinicalTrials.gov registry record

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

A clinical trial of HIV Infections and Osteoporosis, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
450
Enrollment target
20
Study locations

NCT00069004: Completed study of HIV Infections and Osteoporosis, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT00069004 is a study of HIV Infections and Osteoporosis that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 450 participants, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target. The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00069004, a study of HIV Infections and Osteoporosis, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
450 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to assess the prevalence of metabolic and physical abnormalities in HIV infected (via mother-to-child transmission) and uninfected children and youth. Metabolism, body composition, bone density, and other factors will be assessed in relationship to participants' exposure to highly active antiretroviral therapy (HAART).

Study Locations (20)

California

  • Usc La Nichd Crs - Alhambra
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. - Long Beach
  • UCSD Mother-Child-Adolescent Program CRS - San Diego
  • UCSF Pediatric AIDS CRS - San Francisco
  • Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases - Torrance

Florida

  • South Florida CDTC Ft Lauderdale NICHD CRS - Fort Lauderdale
  • Univ. of Florida College of Medicine-Dept of Peds, Div. of Immunology, Infectious Diseases & Allergy - Gainesville
  • USF - Tampa NICHD CRS - Tampa

District of Columbia

  • Children's National Med. Ctr., ACTU - Washington D.C.
  • Howard Univ. Washington DC NICHD CRS - Washington D.C.

Illinois

  • Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program - Chicago
  • Chicago Children's CRS - Chicago

Alabama

  • UAB, Dept. of Ped., Div. of Infectious Diseases - Birmingham

Colorado

  • Univ. of Colorado Denver NICHD CRS - Aurora

Connecticut

  • Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease - New Haven

Georgia

  • Med. College of Georgia School of Medicine, Dept. of Peds., Div. of Infectious Diseases - Augusta

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2003-10
Est. Completion 2005-08

What the finished NCT00069004 record still lists

NCT00069004 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 445-participant average among 542 other HIV Infections trials with a reported enrollment target.

The record links to 7 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00069004 names 20 study sites across 12 states, led by California, Florida, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00069004 about?

NCT00069004 is a clinical study titled "A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth". The purpose of this study is to assess the prevalence of metabolic and physical abnormalities in HIV infected (via mother-to-child transmission) and uninfected children and youth. Metabolism, body composition, bone density, and other factors will be assessed in relationship to participants' exposure...

What is the current status of trial NCT00069004?

This trial is currently completed. The enrollment target is 450 participants. The study started on 2003-10. Estimated completion is 2005-08.

What conditions does trial NCT00069004 study?

This clinical trial studies the following conditions: HIV Infections, Osteoporosis, Dyslipidemia, Lipodystrophy, Osteopenia.

Who is sponsoring clinical trial NCT00069004?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00069004 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00069004's enrollment target sits among peer trials

450 73rd of 542 higher than 469 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00069004, the US trial registry maintained by the National Library of Medicine. NCT00069004 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.